Linghui Lu

2.7k citations
53 papers · 2.4k indexed · 1 hit paper · h-index 23

Linghui Lu

50 papers receiving 2.3k citations

Hit Papers

Recent advances of 1,2,3,5-tetrakis(carbazol-9-yl)-4,6-di...5552019202620212023100200300400500

Peers

Linghui Lu
Comparison fields: 5 of 98
  • Organic Chemistry 1.5k
  • Pharmaceutical Science 137
  • Complementary and alternative medicine 174
  • Toxicology 72
  • Process Chemistry and Technology 41
Replace Congde Huo with:
Congde Huo China
Xiangbao Meng China
Arthur Eugen Kümmerle Brazil
Jinwen Huang China
Xiaojie Lu China
Antonio Scilimati Italy
Yongnan Xu China
Chao Pi China
Thomas J. Maimone United States
Biao Xiong China
Linghui Lu relative to Congde Huo China Congde Huo's profile →
Citations per field
00.5×2.9×
Congde Huo · 1×
Citations per year

Countries citing papers authored by Linghui Lu

Since Specialization
Citations

This map shows the geographic impact of Linghui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghui Lu more than expected).

Fields of papers citing papers by Linghui Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linghui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghui Lu. The network helps show where Linghui Lu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Linghui Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linghui Lu Line = papers co-authored together Linghui Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20237
3 202320
4 20234
5 20224
6 202214
7 202242
8 202131
9 202118
10 202115
11 20186
12 20186
13 201749
14 201710
15 20161
16 201618
17 201655
18 201527
19 20152
20 20144

About Linghui Lu

Linghui Lu is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 53 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sulfur-Based Synthesis Techniques (9 papers), Chemical Synthesis and Reactions (7 papers), Traditional Chinese Medicine Analysis (6 papers), Cancer-related molecular mechanisms research (5 papers), Cardiac Fibrosis and Remodeling (5 papers), RNA modifications and cancer (4 papers), Signaling Pathways in Disease (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Organic Chemistry (1.5k citations), Pharmaceutical Science (137 citations) and Complementary and alternative medicine (174 citations). Linghui Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wei‐Min He, Zhong Cao, Yan Liu, Tianyi Shang, Bing Yu, Xinhua Xu, Yong Wang, Zilong Tang, Qiyan Wang and Chao Wu. Their work appears in journals such as Green Chemistry, ACS Sustainable Chemistry & Engineering, Biomedicine & Pharmacotherapy, Scientific Reports and Organic & Biomolecular Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026